Point72 Asset Management
GH icon

Point72 Asset Management’s Guardant Health GH Stock Holding History

Point72 Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138M Buy
920,807
+224,867
+32% +$24.5M 0.15% 134
2026
Q1 		$64.3M Sell
695,940
-803,229
-54% -$80.6M 0.08% 282
2025
Q4 		$153M Buy
1,499,169
+1,396,754
+1,364% +$125M 0.17% 97
2025
Q3 		$6.4M Buy
102,415
+46,115
+82% +$2.51M 0.01% 974
2025
Q2 		$2.93M Sell
56,300
-720,270
-93% -$32.2M 0.01% 1159
2025
Q1 		$33.1M Sell
776,570
-96,512
-11% -$4.16M 0.08% 310
2024
Q4 		$26.7M Buy
+873,082
New +$24.6M 0.06% 368
2024
Q3 		– Sell
-1,815,053
Closed -$52.4M – 2119
2024
Q2 		$52.4M Buy
1,815,053
+388,603
+27% +$9.05M 0.14% 206
2024
Q1 		$29.4M Buy
+1,426,450
New +$30.6M 0.07% 329
2023
Q4 		– Sell
-60,879
Closed -$1.6M – 2384
2023
Q3 		$1.8M Sell
60,879
-2,653,406
-98% -$93.3M 0.01% 1161
2023
Q2 		$97.2M Buy
+2,714,285
New +$78M 0.29% 80
2022
Q4 		– Sell
-178,942
Closed -$8.19M – 1613
2022
Q3 		$9.63M Buy
+178,942
New +$9.19M 0.04% 512
2022
Q1 		– Sell
-82,100
Closed -$8.21M – 1244
2021
Q4 		$8.21M Buy
+82,100
New +$8.49M 0.03% 558
2021
Q3 		– Sell
-93,596
Closed -$11.6M – 1117
2021
Q2 		$11.6M Buy
+93,596
New +$12.6M 0.05% 417
2021
Q1 		– Sell
-36,360
Closed -$4.69M – 1037
2020
Q4 		$4.69M Sell
36,360
-154,856
-81% -$17.8M 0.02% 591
2020
Q3 		$21.4M Buy
+191,216
New +$17.5M 0.11% 259
2020
Q1 		– Sell
-94,646
Closed -$7.4M – 887
2019
Q4 		$7.4M Sell
94,646
-670,377
-88% -$48.3M 0.04% 438
2019
Q3 		$48.8M Buy
765,023
+759,442
+13,608% +$66.9M 0.3% 88
2019
Q2 		$482K Buy
5,581
+909
+19% +$69.4K ﹤0.01% 842
2019
Q1 		$358K Buy
+4,672
New +$259K ﹤0.01% 902

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Point72 Asset Management's GH Position: Q2 2026 in Review

Point72 Asset Management increased its Guardant Health (GH) stake by 32% in Q2 2026, buying an estimated $24.5M and bringing the position to 920,807 shares worth $138M. The position accounts for 0.15% of the portfolio, ranked #134.

Point72 Asset Management first reported a position in GH in Q1 2019 and has held it in 20 quarters since. The position peaked at $153M in Q4 2025. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Point72 Asset Management held 920,807 shares of Guardant Health worth $138M as of Q2 2026.
  • Point72 Asset Management bought 224,867 Guardant Health shares in Q2 2026, an estimated $24.5M.
  • Guardant Health made up 0.15% of Point72 Asset Management's portfolio in Q2 2026, its #134 holding.
  • Point72 Asset Management first reported a position in Guardant Health in Q1 2019 and has held it in 20 quarters since.
  • Point72 Asset Management's Guardant Health position peaked at $153M in Q4 2025.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.